Robeco Institutional Asset Management
AVNS

Robeco Institutional Asset Management’s Avanos Medical AVNS Stock Holding History

Robeco Institutional Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,917
Closed -$201K – 1101
2023
Q3 		$201K Hold
9,917
– – ﹤0.01% 927
2023
Q2 		$253K Buy
+9,917
New +$261K ﹤0.01% 925

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Robeco Institutional Asset Management's AVNS Position: Q4 2023 in Review

Robeco Institutional Asset Management sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 9,917 shares — an estimated $201K sold.

Robeco Institutional Asset Management first reported a position in AVNS in Q2 2023 and held it in 2 quarters. The position peaked at $253K in Q2 2023. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

  • Robeco Institutional Asset Management reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 9,917 Avanos Medical shares in Q4 2023, an estimated $201K.
  • Robeco Institutional Asset Management first reported a position in Avanos Medical in Q2 2023 and held it in 2 quarters.
  • Robeco Institutional Asset Management's Avanos Medical position peaked at $253K in Q2 2023.
  • 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.